Acadia Healthcare Company, Inc.
For the period ended Dec 31, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 27, 2026
ACHC$38.64+0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
(a)
The following documents are filed as part of this Annual Report on Form 10-K:
Consolidated Financial Statements :
The consolidated financial statements required to be included in Part II, Item 8, Financial Statements and Supplementary Data, begin on Page F-1 and are submitted as a separate section of this report.
Financial Statement Schedules :
All schedules are omitted because they are not applicable or are not required, or because the required information is included in the consolidated financial statements or notes in this report.
Exhibits :
| ExhibitNo. | Exhibit Description |
| 3.1 | Amended and Restated Certificate of Incorporation, as amended. (a) |
| 3.2 | Amended and Restated Bylaws of the Company, as amended. (b) |
| 4.1 | Indenture, dated June 24, 2020, by and among the Company, the guarantors party thereto and U.S. Bank National Association, as Trustee. (c) |
| 4.2 | Form of 5.500% Senior Note due 2028 (included as Exhibit A1 in Exhibit 4.1). |
| 4.3 | Indenture, dated October 14, 2020, by and among the Company, the guarantors party thereto and U.S. Bank National Association, as Trustee. (d) |
| 4.4 | Form of 5.000% Senior Note due 2029 (included as Exhibit A1 in Exhibit 4.3). |
| 4.5 | Indenture, dated March 10, 2025, by and among the Company, the guarantors party thereto and U.S. BankTrust Company, National Association, as Trustee. (e) |
| 4.6 | Form of 7.375% Senior Note due 2033 (included as Exhibit A1 in Exhibit 4.5). |
| 4.7 | Amended and Restated Stockholders Agreement, dated as of October 29, 2014, by and among the Company and each of the stockholders named therein. (f) |
| 4.8 | Specimen Common Stock Certificate to be issued to holders of the Company’s Common Stock. (g) |
| 4.9 | Third Amended and Restated Registration Rights Agreement, dated as of December 31, 2015, by and among the Company and each of the parties named therein. (h) |
| 4.10 | Joinder, dated February 16, 2016, to the Third Amended and Restated Registration Rights Agreement dated as of December 31, 2015, by and among the Company and each of the parties named therein. (i) |
| 4.11 | Description of the Company’s Securities. (j) |
| 10.1 | Credit Agreement, dated as of March 17, 2021, by and among the Company, certain subsidiaries of the Company, as guarantors, the several banks and other financial institutions as may from time to time become parties thereunder as lenders, and Bank of America, N.A., as Administrative Agent and Swingline Lender. (k) |
| 10.2 | Amendment No. 1 to Credit Agreement, dated as of March 30, 2023, by and among the Company, certain subsidiaries of the Company, as guarantors, the several banks and other financial institutions as may from time to time become parties thereunder as lenders, and Bank of America, N.A., as Administrative Agent and Swingline Lender. (l) |
| 10.3 | Amendment No. 2 to Credit Agreement, dated as of January 18, 2024, by and among the Company, certain subsidiaries of the Company, as guarantors, the several banks and other financial institutions as may from time to time become parties thereunder as lenders, and Bank of America, N.A., as Administrative Agent and Swingline Lender. (m) |
| 10.4 | Security and Pledge Agreement, dated as of March 17, 2021, by and among the Company, the other obligors party thereto and Bank of America, N.A., as Administrative Agent. (k) |
| 10.5 | Credit Agreement, dated as of February 28, 2025, among the Company, the several banks and other financial institutions as may from time to time become parties thereunder as lenders, and JPMorgan Chase Bank, N.A., as Administrative Agent. (n) |
| †10.6 | Employment Agreement, dated as of January 19, 2026, by and between Acadia Management Company, Inc. and Debra K. Osteen. (o) |
| †10.7 | Employment Agreement, dated October 7, 2025, by and between Acadia Management Company, Inc. and Todd Young. (p) |
| †10.8 | Employment Agreement, dated June 30, 2023, by and between Acadia Management Company, Inc. andBrian Farley. (q) |
| †10.9 | First Amendment to Employment Agreement, dated July 6, 2023, by and between Acadia ManagementCompany, Inc. and Brian Farley, dated as of June 30, 2023. (q) |
| †10.10 | Employment Agreement, dated March 31, 2022, by and among the Company, Acadia Management Company, Inc. and Christopher H. Hunter. (r) |
| †10.11 | Separation and Release Agreement, dated January 20, 2026, between Acadia Management Company, LLCand Christopher Hunter. (s) |
| †10.12 | Employment Agreement, dated June 1, 2023, by and between Acadia Management Company, Inc. and Heather B. Dixon. (t) |
| †10.13 | Employment Agreement, dated May 23, 2024, by and between Acadia Management Company, Inc. and Dr. Nasser Khan. (a) |
| †10.14 | Transition and Separation Agreement, dated October 31, 2025, between Acadia Management Company, Inc. and Dr. Nasser Khan. (u) |
| †10.15* | Severance Agreement, dated April 29, 2022, by and between Acadia Management Company, Inc. and Timothy Sides. |
| †10.16 | Form of Cash Retention Award Agreement. (v) |
| †10.17 | Cash Retention Award Agreement, dated as of July 25, 2025, by and between Acadia Management Company, LLC and Brian Farley. (w) |
| †10.18 | Cash Retention Award Agreement, dated as of July 25, 2025, by and between Acadia Management Company, LLC and Dr. Nasser Khan. (w) |
| †10.19 | Cash Retention Award Agreement, dated as of December 19, 2024, by and between Acadia Management Company, LLC and Timothy Sides, as amended as of August 6, 2025. (w) |
| †10.20 | Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. (x) |
| †10.21 | Amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. (y) |
| †10.22 | Form of Restricted Stock Unit Agreement. (z) |
| †10.23 | Form of Incentive Stock Option Agreement. (aa) |
| †10.24 | Form of Non-Qualified Stock Option Agreement. (aa) |
| †10.25 | Form of Restricted Stock Agreement. (z) |
| †10.26 | Form of Stock Appreciation Rights Agreement. (aa) |
| †10.27 | Acadia Healthcare Company, Inc. Nonqualified Deferred Compensation Plan, effective February 1, 2013. (bb) |
| †10.28 | Nonmanagement Director Compensation Program, effective January 1, 2013. (bb) |
| 10.29 | Form of Indemnification Agreement (for directors and officers affiliated with Waud Capital Partners). (cc) |
| 10.30 | Form of Indemnification Agreement (for directors and officers not affiliated with Waud Capital Partners). (cc) |
| 10.31 | Settlement Agreement, Release in Full and Indemnification Agreement, dated October 30, 2023, by and among Acadia Healthcare Company, Inc., Youth and Family Centered Services of New Mexico, Inc. d/b/a Desert Hills, and Shasta N. Inman, as Guardian Ad Litem. (dd) |
| 10.32 | Settlement Agreement, Release in Full and Indemnification Agreement, dated October 30, 2023, by and among Acadia Healthcare Company, Inc., Youth and Family Centered Services of New Mexico, Inc. d/b/a Desert Hills, and Feliz Rael, as Guardian Ad Litem. (dd) |
| 10.33 | Settlement Agreement, Release in Full and Indemnification Agreement, dated October 30, 2023, by and among Acadia Healthcare Company, Inc., Youth and Family Centered Services of New Mexico, Inc. d/b/a Desert Hills, and Alison Endicott-Quiñones, as Guardian Ad Litem. (dd) |
| 19 | Acadia Healthcare Company. Inc. Insider Trading Policy. (ee) |
| 21* | Subsidiaries of the Company. |
| 22 | List of Subsidiary Guarantors and Issuers of Guaranteed Securities. (w) |
| 23* | Consent of Independent Registered Public Accounting Firm. |
| 31.1* | Rule 13a-14(a) Certification of the Chief Executive Officer of the Company pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 31.2* | Rule 13a-14(a) Certification of the Chief Financial Officer of the Company pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 32.1** | Section 1350 Certification of Chief Executive Officer of the Company pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 32.2** | Section 1350 Certification of Chief Financial Officer of the Company pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 97 | Acadia Healthcare Company, Inc. Policy Regarding the Mandatory Recovery of Compensation. (ff) |
| 101.INS*** | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH*** | Inline XBRL Taxonomy Extension Schema with embedded Linkbase Document. |
| 104 | The cover page from the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, has been formatted in Inline XBRL. |
| † | Indicates management contract or compensatory plan or arrangement. |
| * | Filed herewith. |
| ** | Furnished herewith. |
| *** | The XBRL related information in Exhibit 101 to this Annual Report on Form 10-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document. |
| (a) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed on May 24, 2024 (File No. 001-35331). |
| (b) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed May 25, 2017 (File No. 001-35331). |
| (c) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed June 24, 2020 (File No. 001-35331). |
| (d) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed October 14, 2020 (File No. 001-35331). |
| (e) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed March10, 2025 (File No. 001-35331). |
| (f) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed October 30, 2014 (File No. 001-35331). |
| (g) | Incorporated by reference to exhibits filed with the Company’s registration statement on Form S-1, as amended (File No. 333-175523), originally filed with the SEC on November 23, 2011. |
| (h) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed January 4, 2016 (File No. 001-35331). |
|---|---|
| (i) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed February 16, 2016 (File No. 001-35331). |
| (j) | Incorporated by reference to exhibits filed with the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 (File No. 001-35331). |
| (k) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 10-Q for the three months ended March 31, 2021 (File No. 001-35331). |
| (l) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 10-Q for the three months ended March 31, 2023 (File No. 001-35331). |
| (m) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed January 19, 2024 (File No. 001-35331). |
| (n) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed February 28, 2025 (File No. 001-35331). |
| (o) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed January 20, 2026 (File No. 001-35331). |
| (p) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed October 7, 2025 (File No. 001-35331). |
| (q) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 10-Q for the threemonths ended June 30, 2023 (File No. 001-35331). |
| (r) | Incorporated by reference to exhibits filed with the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2022 (File No. 001-35331). |
| (s) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed January 23, 2026 (File No. 001-35331). |
| (t) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed June 2, 2023 (File No. 001-35331). |
| (u) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed November 5, 2025 (File No. 001-35331). |
| (v) | Incorporated by reference to exhibits filed with the Company’s Quarterly Report on Form 10-Q for the three months ended June 30, 2025 (File No. 001-35331). |
| (w) | Incorporated by reference to exhibits filed with the Company’s Quarterly Report on Form 10-Q for the three months ended September 30, 2025 (File No. 001-35331). |
| (x) | Incorporated by reference to Appendix B to the Company’s Definitive Proxy Statement filed April 10, 2025 (File No. 001-35331). |
| (y) | Incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement filed April 10, 2025 (File No. 001-35331). |
| (z) | Incorporated by reference to exhibits filed with the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2018 (File No. 001-35331). |
| (aa) | Incorporated by reference to exhibits filed with the Company’s registration statement on Form S-4, as amended (File No. 333-175523), originally filed with the SEC on July 13, 2011. |
| (bb) | Incorporated by reference to exhibits filed with the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2013 (File No. 001-35331). |
| (cc) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed November 1, 2011 (File No. 001-35331). |
| (dd) | Incorporated by reference to exhibits filed with the Company’s Current Report on Form 8-K filed October 30, 2023 (File No. 001-35331). |
| (ee) | Incorporated by reference to exhibits filed with the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 (File No. 001-35331). |
| (ff) | Incorporated by reference to exhibits filed with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (File No. 001-35331). |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.